Ilumya is prescribed to treat moderate to severe plaque psoriasis. Plaque psoriasis is an autoimmune disease that primarily affects the skin.
As your immune system turns against you and begins to attack healthy skin cells, plaque inflamed, scaly patches will begin forming on your skin in various locations throughout your body. These scaly patches of skin, known as plaques will appear as red or pink patches covered with silvery scales. On dark skin, plaques can appear thicker, ranging from dark brown, purple, or light gray.
Ilumya works by halting the body’s autoimmune response by blocking a cytokine known as interleukin-23 (IL-23). IL-23 may be in part responsible for the activation of interleukin-17 (IL-17) and Tumor Necrosis Factor- Alpha (TNF-Alpha), which helps fight of infection and disease.
However, if IL-17 and TNF-Alpha are overproduce in the body, especially when they are immune properties are not needed, it can lead to healthy tissues being attacked. By blocking IL-23, it helps limits the activity of both Il-17 and TNF-Alpha, which has shown to reduce inflammation is psoriatic lesions.
Before your infusion, it is important to drink plenty of water and come to your appointment hydrated. Additionally, you must alert us as soon as possible to any changes in your insurance to ensure that we are still an in-network provider for your infusion therapy.